Volume Spike Investor

Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI) announced that Cook Medical, a license holder of its paclitaxel technology, reported a CE Mark approval and limited commercial launch of the Zilver PTX Drug-Eluting Peripheral Stent in Europe.  This cover peripheral artery disease.  Shares are up over 30% at $2.20 at 8:30 AM EST on over 200,000 shares.  The 52-week high is $2.94 and it trades 2.8 million shares on average. -JON OGG